New Jersey to legalize medical marijuana

NewsGuard 100/100 Score

The New York Times: "The New Jersey Legislature approved a measure on Monday that would make the state the 14th in the nation, but one of the few on the East Coast, to legalize the use of marijuana to help patients with chronic illnesses. The measure — which would allow patients diagnosed with severe illnesses like cancer, AIDS, Lou Gehrig's disease, muscular dystrophy and multiple sclerosis to have access to marijuana grown and distributed through state-monitored dispensaries — was passed by the General Assembly and State Senate on the final day of the legislative session" (Kocieniewski, 1/11).

The Philadelphia Inquirer: "Last February, the state Senate approved a medical-marijuana bill with bipartisan support. But after critics raised concerns that the bill could allow marijuana to become too readily available, sponsors tightened restrictions" (Lu, 1/12).

The Star-Ledger: "Gov. Jon Corzine has said he would sign the bill into law before he leaves office Jan. 19. ... The law would forbid people from growing their own marijuana, license 'alternate treatment centers' to dispense the drug, and require designated caretakers who retrieve the drug on behalf of a severely ill person to undergo criminal background checks" (1/11).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Aspirin shows no benefit in preventing breast cancer recurrence, study finds